Research that aims
to prevent the next attack.
A new generation of therapies is being studied to lower triglycerides more deeply, and more durably, than ever before. Clinical trials are how those treatments reach the people who need them.
what you’ll find on this page
What a trial is
A carefully designed study testing a new treatment for safety and effectiveness, reviewed by an independent ethics board. Participation is always voluntary.
Why TiP research matters
RNA-based therapies targeting pathways such as APOC3 and ANGPTL3 are being studied for triglyceride lowering and potential pancreatitis-risk reduction in people with severe triglyceride disorders.
Questions to ask
What phase is the study, what’s the comparison group, what are the risks and benefits, costs, time commitment, and what happens after the trial ends?